EU Transdermal Patch: Generic Submission [Design Issues]

posted by HallaGulla – 2023-03-08 09:58 (405 d 04:15 ago) – Posting: # 23491
Views: 1,002

(edited by on 2023-03-08 11:11)

Hi All

One of the clients with whom I am working is developing a generic transdermal patch for UK/EU submission.

They are asking us to do the PK study, Adhesion study and skin senstization study in either EU/UK or in USA due to simialr climatic condition.

My question is, can these studies be done in India or any other countries? Does MHRA/EMA accepts transdermal studies done in the geographies which has a different climatic conditions?


TIA...


Edit: Category changed; see also this post #1. Are you really located in Japan? ;-) [Helmut]

:lol: Shhhhh

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,650 registered users;
42 visitors (0 registered, 42 guests [including 4 identified bots]).
Forum time: 15:14 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5